You may subscribe to this RSS feed.
- United States Consensus Guidance for the Uniform Labeling of Cellular Therapy Products Using ISBT 128 v1.3.0 Now Available
- ISBT 128 Technical Specification v5.1.0 Now Available
- The Registered Facilities Database is Now Available
- Version 5.2.0 of the Product Description Codes Database is Now Available
- Development of the guidance document on the use of GS1 and ISBT 128 for the unique device identification of medical devices
ISBT 128 - The Global Information Standard for Medical Products of Human Origin
ISBT 128 is the global standard for the terminology, identification, coding and labeling of medical products of human origin (including blood, cell, tissue, milk, and organ products). It is used in more than 77 countries across six continents and disparate health care systems. It is widely endorsed by the professional community.
The standard has been designed to ensure the highest levels of accuracy, safety, and efficiency for the benefit of donors and patients worldwide. ISBT 128 provides international consistency to support the transfer, traceability and transfusion/transplantation of blood, cells, tissues and organs.
ICCBBA – An NGO in Official Relations with the World Health Organization
ICCBBA, the international standards organization responsible for the management and development of the ISBT 128 Standard, is a not-for-profit nongovernmental organization in official relations with the World Health Organization (WHO). For more information please view ICCBBA's press release.The acronym ISBT was originally derived from the important role played by the International Society of Blood Transfusion in the development of the standard. Today it expands as Information Standard for Blood and Transplant. The number 128 reflects the 128 characters of the ISO/IEC 646 7-bit character set.
The acronym ICCBBA is derived from the International Council for Commonality in Blood Banking Automation.
To register, click the banner above, or follow: http://www.udiconference.com
UDI Conference (October 28-29, 2014): Dedicated to guidance and training for those impacted by the new UDI Regulation: Medical device manufacturers, Health care distributors, Group purchasing organizations, Hospitals / health care providers, and Health care industry professionals.